Development and Validation of the Biomedical Research Trust Scale (BRTS) in English and Spanish

Abstract

This study developed and validated the Biomedical Research Trust Scale (BRTS), a 10-item measure of global trust in biomedical research, in English and Spanish (BRTS-SP). In total, 85 English- and 85 Spanish-speaking participants completed the BRTS or BRTS-SP, as well as measures of biobanking attitudes, self-efficacy, receptivity, and intentions to donate blood or urine. Results indicated the BRTS and BRTS-SP showed adequate internal consistency in both English and Spanish. In addition, greater levels of trust in biomedical research were significantly associated with greater self-efficacy, receptivity, attitudes, and intentions to donate blood and urine in English-speaking participants, and self-efficacy and intention to donate urine in Spanish-speaking participants. These results support the use of the BRTS and BRTS-SP among English- and Spanish-speaking community members.

Keywords

biomedical research biobanking biospecimen donation trust survey questionnaire reliability validity

Get full access to this article

View all access options for this article.

References

Anderson

L. A.

Dedrick

R. F.

(1990). Development of the Trust in Physician scale: A measure to assess interpersonal trust in patient-physician relationships. Psychological Reports, 67(3, Pt. 2), 1091-1100.

Areán

P. A.

Gallagher-Thompson

(1996). Issues and recommendations for the recruitment and retention of older ethnic minority adults into clinical research. Journal of Consulting and Clinical Psychology, 64, 875-880.

Arevalo

Jacobsen

P. B.

Gwede

C. K.

Meade

C. D.

Quinn

G. P.

Wells

K. J.

(in press). Development and validation of the Spanish Biobanking Attitudes and Knowledge Survey (BANKS-SP). Journal of Community Genetics.

Armstrong

T. D.

Crum

L. D.

Rieger

R. H.

Bennett

T. A.

Edwards

L. J.

(1999). Attitudes of African Americans toward participation in medical research. Journal of Applied Social Psychology, 29, 552-574.

Beskow

L. M.

Dean

(2008). Informed consent for biorepositories: Assessing prospective participants’ understanding and opinions. Cancer Epidemiology, Biomarkers & Prevention, 17, 1440-1451.

Biomedical Research. (2006). OECD—Glossary of Statistical Terms. Retrieved from http://stats.oecd.org/glossary/detail.asp?ID=217

Brislin

R. W.

(1970). Back-translation for cross-cultural research. Journal of Cross-Cultural Psychology, 1, 185-216.

Bussey-Jones

Garrett

Henderson

Moloney

Blumenthal

Corbie-Smith

(2010). The role of race and trust in tissue/blood donation for genetic research. Genetics in Medicine, 12, 116-121.

California Biomedical Research Association. (n.d.). Fact sheet: What is biomedical research? Retrieved from http://ca-biomed.org/pdf/media-kit/fact-sheets/FS-WhatBiomedical.pdf

10.

Centers for Disease Control and Prevention, National Office of Public Health Genomics. (2007). 10 years of public health genomics at CDC 1997-2007. Atlanta, GA: National Office of Public Health Genomics, Centers for Disease Control and Prevention.

11.

Chang

S. M.

Barker

F. G.

Schmidt

M. H.

Sloan

A. E.

Kasper

Phillips

. . . Berger

M. S.

(2002). Clinical trial participation among patients enrolled in the Glioma Outcomes Project. Cancer, 94, 2681-2687.

12.

Cohen

(1988). Statistical power analysis for the behavioral sciences (2nd ed.). New York, NY: Academic Press.

13.

Corbie-Smith

Thomas

S. B.

George

D. M. M. S

. (2002). Distrust, race, and research. Archives of Internal Medicine, 162, 2458-2463.

14.

Crawley

L. M.

(2001). African-American participation in clinical trials: Situating trust and trustworthiness. Journal of the National Medical Association, 93(Suppl. 12), 14S-17S.

15.

Critchley

C. R.

Nicol

Otlowski

M. F.

Stranger

M. J.

(2012). Predicting intention to biobank: A national survey. European Journal of Public Health, 22, 139-144.

16.

DeVellis

R. F.

(2003). Scale development: Theory and applications. Thousand Oaks, CA: SAGE.

17.

Durant

R. W.

Legedza

A. T.

Marcantonio

E. R.

Freeman

M. B.

Landon

B. E.

(2011). Willingness to participate in clinical trials among African Americans and whites previously exposed to clinical research. Journal of Cultural Diversity, 18, 8-19.

18.

Earl

C. E.

Penney

P. J.

(2001). The significance of trust in the research consent process with African Americans. Western Journal of Nursing Research, 23, 753-762.

19.

Ellington

Wahab

Sahami Martin

Field

Mooney

K. H.

(2006). Factors that influence Spanish- and English-speaking participants’ decision to enroll in cancer randomized clinical trials. Psycho-Oncology, 15, 273-284.

20.

Gamble

V. N.

(1993). A legacy of distrust: African Americans and medical research. American Journal of Preventive Medicine, 9(Suppl. 12), 35-38.

21.

Giuliano

A. R.

Mokuau

Hughes

Tortolero-Luna

Risendal

R. C. S.

. . . McCaskill-Stevens

W. J.

(2000). Participation of minorities in cancer research: The influence of structural, cultural, and linguistic factors. Annals of Epidemiology, 10(Suppl. 8), S22-S34.

22.

Godard

Marshall

Laberge

(2007). Community engagement in genetic research: Results of the first public consultation for the Quebec CARTaGENE project. Public Health Genomics, 10, 147-158.

23.

Gustafsson Stolt

Liss

P.-E.

Svensson

Ludvigsson

. (2002). Attitudes to bioethical issues: A case study of a screening project. Social Science & Medicine, 54, 1333-1344.

24.

Haddow

Cunningham-Burley

Bruce

Parry

(2008). Generation Scotland: Consulting publics and specialists at an early stage in a genetic database’s development. Critical Public Health, 18, 139-149.

25.

Hall

M. A.

Camacho

Dugan

Balkrishnan

(2002). Trust in the medical profession: Conceptual and measurement issues. Health Services Research, 37, 1419-1439.

26.

Hall

M. A.

Camacho

Lawlor

J. S.

DePuy

Sugarman

Weinfurt

(2006). Measuring trust in medical researchers. Medical Care, 11, 1048-1053.

27.

Halverson

C. M. E.

Ross

L. F.

(2012). Attitudes of African-American parents about biobank participation and return of results for themselves and their children. Journal of Medical Ethics, 38, 561-566.

28.

Haynes-Maslow

Godley

Dimartino

White

Odom

Richmond

Carpenter

(2014). African American women’s perceptions of cancer clinical trials. Cancer Medicine, 3, 1430-1439.

29.

Hewitt

R. E.

(2011). Biobanking: The foundation of personalized medicine. Current Opinion in Oncology, 23, 112-119.

30.

Hodge

F. S.

Weinmann

Roubideaux

(2000). Recruitment of American Indians and Alaska Natives into clinical trials. Annals of Epidemiology, 10(Suppl. 8), S41-S48.

31.

IBM Corp. (2013). IBM SPSS Statistics for Windows (Version 22.0). Armonk, NY: Author.

32.

Jenkins

Fallowfield

(2000). Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy. British Journal of Cancer, 82, 1783-1788.

33.

Jones

P. S.

Lee

J. W.

Phillips

L. R.

Zhang

X. E.

Jaceldo

K. B.

(2001). An adaptation of Brislin’s translation model for cross-cultural research. Nursing Research, 50, 300-304.

34.

Kaphingst

K. A.

Janoff

J. M.

Harris

L. N.

Emmons

K. M.

(2006). Views of female breast cancer patients who donated biologic samples regarding storage and use of samples for genetic research. Clinical Genetics, 69, 393-398.

35.

Kaufman

Geller

Leroy

Murphy

Scott

Hudson

(2008). Ethical implications of including children in a large biobank for genetic-epidemiologic research: A qualitative study of public opinion. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 148, 31-39.

36.

Kettis-Lindblad

Ring

Viberth

Hansson

M. G.

(2006). Genetic research and donation of tissue samples to biobanks. What do potential sample donors in the Swedish general public think? European Journal of Public Health, 16, 433-440.

37.

LaVeist

T. A.

Nickerson

K. J.

Bowie

J. V.

(2000). Attitudes about racism, medical mistrust, and satisfaction with care among African American and white cardiac patients. Medical Care Research and Review, 57(Suppl. 4), 146-161.

38.

Leisen

Hyman

M. R.

(2001). An improved scale for assessing patients’ trust in their physician. Health Marketing Quarterly, 19, 23-42.

39.

Lemke

A. A.

Halverson

Ross

L. F.

(2012). Biobank participation and returning research results: Perspectives from a deliberative engagement in South Side Chicago. American Journal of Medical Genetics Part A, 158, 1029-1037.

40.

Lemke

A. A.

Wolf

W. A.

Hebert-Beirne

Smith

M. E.

(2010). Public and biobank participant attitudes toward genetic research participation and data sharing. Public Health Genomics, 13, 368-377.

41.

Levitt

Weldon

(2005). A well placed trust? Public perceptions of the governance of DNA databases. Critical Public Health, 15, 311-321.

42.

Lewis

Clotworthy

Hilton

Magee

Robertson

M. J.

Stubbins

L. J.

Corfield

(2013). Public views on the donation and use of human biological samples in biomedical research: A mixed methods study. BMJ Open, 3(8), 1-12.

43.

Luque

J. S.

Quinn

G. P.

Montel-Ishino

F. A.

Arevalo

Bynum

S. A.

Noel-Thomas

. . . Meade

C. D.

(2012). Formative research on perceptions of biobanking: What community members think. Journal of Cancer Education, 27, 91-99.

44.

Mainous

A. G.

Smith

D. W.

Geesey

M. E.

Tilley

B. C.

(2006). Development of a measure to assess patient trust in medical researchers. Annals of Family Medicine, 4, 247-252.

45.

McCabe

M. S.

Varricchio

C. G.

Padberg

R. M.

(1994). Efforts to recruit the economically disadvantaged to national clinical trials. Seminars in Oncology Nursing, 10, 123-129.

46.

McCarty

C. A.

Chapman-Stone

Derfus

Giampietro

P. F.

Fost

(2008). Community consultation and communication for a population-based DNA biobank: The Marshfield Clinic Personalized Medicine Research Project. American Journal of Medical Genetics Part A, 146, 3026-3033.

47.

Nurgat

Z. A.

Craig

Campbell

N. C.

Bissett

J. D.

Cassidy

Nicolson

M. C.

(2005). Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy. British Journal of Cancer, 92, 1001-1005.

48.

Organisation for Economic Co-Operation and Development. (2006). Creation and governance of human genetic research databases. Paris, France: Author.

49.

Ormond

K. E.

Cirino

A. L.

Helenowski

I. B.

Chisholm

R. L.

Wolf

W. A.

(2009). Assessing the understanding of biobank participants. American Journal of Medical Genetics Part A, 149, 188-198.

50.

Ormond

K. E.

Smith

M. E.

Wolf

W. A.

(2010). The views of participants in DNA biobanks. Stanford Journal of Law, Science & Policy, 1, 80-87.

51.

Platt

Bollinger

Dvoskin

Kardia

S. L.

Kaufman

(2013). Public preferences regarding informed consent models for participation in population-based genomic research. Genetics in Medicine, 16, 11-18.

52.

Rahm

A. K.

Wrenn

Carroll

N. M.

Feigelson

H. S.

(2013). Biobanking for research: A survey of patient population attitudes and understanding. Journal of Community Genetics, 4, 445-450.

53.

Roberson

N. L.

(1994). Clinical trial participation: Viewpoints from racial/ethnic groups. Cancer, 74(Suppl. 9), 2687-2691.

54.

Rose

Peters

Shea

J. A.

Armstrong

(2004). Development and testing of the Health Care System Distrust Scale. Journal of General Internal Medicine, 19, 57-63.

55.

Safran

D. G.

Kosinski

Tarlov

A. R.

Rogers

W. H.

Taira

D. A.

Lieberman

Ware

J. E.

(1998). The Primary Care Assessment Survey: Tests of data quality and measurement performance. Medical Care, 36, 728-739.

56.

Secko

D. M.

Preto

Niemeyer

Burgess

M. M.

(2009). Informed consent in biobank research: A deliberative approach to the debate. Social Science & Medicine, 68, 781-789.

57.

Shavers

V. L.

Lynch

C. F.

Burmeister

L. F.

(2001). Factors that influence African-Americans’ willingness to participate in medical research studies. Cancer, 91(Suppl. 1), 233-236.

58.

Simmons

V. N.

Klasko

L. B.

Fleming

Koskan

A. M.

Jackson

N. T.

Noel-Thomas

. . . Quinn

G. P.

(2015). Participatory evaluation of a community-academic partnership to inform capacity-building and sustainability. Evaluation and Program Planning, 52, 19-26.

59.

Skinner

Schildkraut

Calingaert

Hoyo

Crankshaw

Fish

. . . Reid

(2008). Factors associated with African Americans’ enrollment in a national cancer genetics registry. Public Health Genomics, 11, 224-233.

60.

Skolbekken

J.-A.

Ursin

L. Ø.

Solberg

Christensen

Ytterhus

(2005). Not worth the paper it’s written on? Informed consent and biobank research in a Norwegian context. Critical Public Health, 15, 335-347.

61.

Streicher

S. A.

Sanderson

S. C.

Jabs

E. W.

Diefenbach

Smirnoff

Peter

. . . Richardson

L. D.

(2011). Reasons for participating and genetic information needs among racially and ethnically diverse biobank participants: A focus group study. Journal of Community Genetics, 2, 153-163.

62.

Thompson

H. S.

Valdimarsdottir

H. B.

Winkel

Jandorf

Redd

(2004). The Group-Based Medical Mistrust Scale: Psychometric properties and association with breast cancer screening. Preventive Medicine, 38, 209-218.

63.

Vaught

Rogers

Myers

Lim

M. D.

Lockhart

Moore

. . . Compton

(2011). An NCI perspective on creating sustainable biospecimen resources. Journal of the National Cancer Institute Monographs, 2011(42), 1-7.

64.

Volkmann

E. R.

Claiborne

Currier

J. S.

(2009). Determinants of participation in HIV clinical trials: The importance of patients’ trust in their provider. HIV Clinical Trials, 10, 104-109.

65.

Wells

K. J.

Arevalo

Meade

C. D.

Gwede

C. K.

Quinn

G. P.

Luque

J. S.

. . . Reyes

(2014). Development and validation of the Biobanking Attitudes and Knowledge Survey (BANKS). Cancer Epidemiology, Biomarkers & Prevention, 23, 374-382.

66.

Zheng

Hall

Dugan

Kidd

Levine

(2002). Development of a scale to measure patients’ trust in health insurers. Health Services Research, 37, 185-200.